{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:25Z","timestamp":1790710885651,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T00:00:00Z","timestamp":1575331200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41433-019-0687-5","type":"journal-article","created":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T06:03:15Z","timestamp":1575352995000},"page":"161-167","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Systematic reviews and randomised controlled trials on open angle glaucoma"],"prefix":"10.1038","volume":"34","author":[{"given":"Richard","family":"Wormald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Virgili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Azuara-Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,3]]},"reference":[{"key":"687_CR1","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1136\/bjophthalmol-2016-309695","volume":"101","author":"A Law","year":"2017","unstructured":"Law A, Lindsley K, Rouse B, Wormald R, Dickersin K, Li T. Missed opportunity from randomised controlled trials of medical interventions for open-angle glaucoma. Br J Ophthalmol. 2017;101:1315\u20137.","journal-title":"Br J Ophthalmol"},{"key":"687_CR2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1136\/bmj.322.7287.639","volume":"322","author":"S Fraser","year":"2001","unstructured":"Fraser S, Bunce C, Wormald R, Brunner E. Deprivation and late presentation of glaucoma: case-control study. Br Med J. 2001;322:639.","journal-title":"Br Med J"},{"key":"687_CR3","volume-title":"Bright future: a new vision for eye health","author":"MR Steedman","year":"2018","unstructured":"Steedman MR, Taylor K, Kurek N, Khaw PT. Bright future: a new vision for eye health. Doha, Qatar: World Innovation Summit for Health; 2018. ISBN 978-1-912865-03-1"},{"key":"687_CR4","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/bjo.50.10.570","volume":"50","author":"FC Hollows","year":"1966","unstructured":"Hollows FC, Graham PA. Intra-ocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol. 1966;50:570\u201386.","journal-title":"Br J Ophthalmol"},{"key":"687_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archopht.1993.01090010100034","volume":"111","author":"L Rossetti","year":"1993","unstructured":"Rossetti L, Marchetti I, Orzalesi N, Scorpiglione N, Torri V, Liberati A. Randomized clinical trials on medical treatment of glaucoma: are they appropriate to guide clinical practice? Arch Ophthalmol. 1993;111:96\u2013103.","journal-title":"Arch Ophthalmol."},{"key":"687_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJM199304153281507","volume":"328","author":"L Rossett","year":"1993","unstructured":"Rossett L, Orzales N, Liberat A. The medical treatment of open-angle glaucoma. N Engl J Med. 1993;328:1097\u2013106.","journal-title":"N Engl J Med"},{"issue":"6","key":"687_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/archopht.120.6.701","volume":"120","author":"Michael A. Kass","year":"2002","unstructured":"Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701\u201313.","journal-title":"Archives of Ophthalmology"},{"key":"687_CR8","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S0002-9394(98)00272-4","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group.","year":"1998","unstructured":"Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 1998;126:498\u2013505. ISSN 0002-9394","journal-title":"Am J Ophthalmol"},{"key":"687_CR9","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0161-6420(98)97013-0","volume":"105","author":"The AGIS investigators.","year":"1998","unstructured":"The AGIS investigators. The advanced glaucoma intervention study (AGIS): 4. comparison of treatment outcomes within race: Seven-year results. Ophthalmology. 1998;105:1146\u201364. https:\/\/doi.org\/10.1016\/S0161-6420(98)97013-0. ISSN 0161-642.","journal-title":"Ophthalmology"},{"key":"687_CR10","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2004.02.017","volume":"111","author":"Kouros Nouri-Mahdavi","year":"2004","unstructured":"Nouri-Mahdavi Kouros, Hoffman Douglas, Coleman AnneL, Liu Gang, Li Gang, Gaasterland Douglas et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology. 2004;111:1627\u201335. https:\/\/doi.org\/10.1016\/j.ophtha.2004.02.017. ISSN 0161-6420.","journal-title":"Ophthalmology"},{"key":"687_CR11","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M.Early Manifest Glaucoma Trial Group Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120:1268\u201379.","journal-title":"Arch Ophthalmol"},{"key":"687_CR12","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ophtha.2004.11.030","volume":"112","author":"The European Glaucoma Prevention Study (EGPS) Group.","year":"2005","unstructured":"The European Glaucoma Prevention Study (EGPS) Group. Results of the European Glaucoma Prevention Study. Ophthalmology. 2005;112:366\u201375. https:\/\/doi.org\/10.1016\/j.ophtha.2004.11.030.","journal-title":"Ophthalmology"},{"key":"687_CR13","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","volume":"331","author":"C Maier Philip","year":"2005","unstructured":"Maier Philip C, Jens Funk, Schwarzer Guido, Antes Gerd, Falck-Ytter YngveT. Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials. Br Med J. 2005;331:134.","journal-title":"Br Med J"},{"key":"687_CR14","doi-asserted-by":"publisher","unstructured":"Vass C, Hirn C, Sycha T, Findl O, Sacu S, Bauer P, et al. Medical interventions for primary open angle glaucoma and ocular hypertension. Cochrane Database of Systematic Reviews. 2007: CD003167. https:\/\/doi.org\/10.1002\/14651858.CD003167.pub3.","DOI":"10.1002\/14651858.CD003167.pub3"},{"issue":"9975","key":"687_CR15","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(14)62111-5","volume":"385","author":"David F Garway-Heath","year":"2015","unstructured":"Garway-Heath DF, Crabb DP, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, et al. Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet. 2015;385:1295\u2013304. https:\/\/doi.org\/10.1016\/S0140-6736(14)62111-5.","journal-title":"The Lancet"},{"issue":"7","key":"687_CR16","doi-asserted-by":"publisher","first-page":"e004905","DOI":"10.1136\/bmjopen-2014-004905","volume":"4","author":"F. Rowe","year":"2014","unstructured":"Rowe F, Wormald R, Cable R, Acton M, Bonstein K, Bowen M, et al. The sight loss and vision priority setting partnership (SLV-PSP): overview and results of the research prioritisation survey process. BMJ Open. 2014;4:e004905.","journal-title":"BMJ Open"},{"key":"687_CR17","doi-asserted-by":"publisher","unstructured":"Burr J, Azuara\u2010Blanco A, Avenell A, Tuulonen A. Medical versus surgical interventions for open angle glaucoma. Cochrane Database Syst Rev. 2012:CD004399. https:\/\/doi.org\/10.1002\/14651858.CD004399.pub3.","DOI":"10.1002\/14651858.CD004399.pub3"},{"key":"687_CR18","doi-asserted-by":"publisher","unstructured":"Rolim de Moura CR, Paranhos Jr A, Wormald R. Laser trabeculoplasty for open angle glaucoma. Cochrane Database of Systematic Reviews 2007:CD003919. https:\/\/doi.org\/10.1002\/14651858.CD003919.pub2.","DOI":"10.1002\/14651858.CD003919.pub2"},{"key":"687_CR19","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/S0161-6420(94)31120-1","volume":"101","author":"C Migdal","year":"1994","unstructured":"Migdal C, Gregory W, Hitchings R. Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 1994;101:1651\u20136.","journal-title":"Ophthalmology."},{"key":"687_CR20","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","volume":"108","author":"PR Lichter","year":"2001","unstructured":"Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA. et al. the CIGTS Study Group. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943\u201353. https:\/\/doi.org\/10.1016\/S0161-6420(01)00873-9.ISSN 0161-6420.","journal-title":"Ophthalmology"},{"issue":"7","key":"687_CR21","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1136\/bjophthalmol-2017-310902","volume":"102","author":"Anthony J King","year":"2017","unstructured":"King AJ, Fernie G, Azuara-Blanco A, Burr JM, Garway-Heath T, Sparrow JM, et al. Treatment of Advanced Glaucoma Study: a multicentre randomised controlled trial comparing primary medical treatment with primary trabeculectomy for people with newly diagnosed advanced glaucoma\u2014study protocol. Br J Ophthalmol. 2018;102:922\u20138.","journal-title":"British Journal of Ophthalmology"},{"key":"687_CR22","unstructured":"National Institute of Clinical Excellence. Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension. http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG85QuickRefGuide.pdf (2009)"},{"key":"687_CR23","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","volume":"393","author":"G Gazzard","year":"2019","unstructured":"Gazzard G, Konstantakopoulou E, Garway-Heath D, Garg A, Vickerstaff V, Hunter R, et al. LiGHT Trial Study Group. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet 2019;393:1505\u201316.","journal-title":"Lancet"},{"key":"687_CR24","doi-asserted-by":"publisher","unstructured":"Green E, Wilkins M, Bunce C, Wormald R. 5\u2010Fluorouracil for glaucoma surgery. Cochrane Database Syst Rev. 2014: CD001132. https:\/\/doi.org\/10.1002\/14651858.CD001132.pub2.","DOI":"10.1002\/14651858.CD001132.pub2"},{"key":"687_CR25","doi-asserted-by":"publisher","unstructured":"Wilkins M, Indar A, Wormald R. Intraoperative Mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005: CD002897. https:\/\/doi.org\/10.1002\/14651858.CD002897.pub2.","DOI":"10.1002\/14651858.CD002897.pub2"},{"key":"687_CR26","doi-asserted-by":"publisher","unstructured":"Cabourne E, Clarke JCK, Schlottmann PG, Evans JR. Mitomycin C versus 5\u2010Fluorouracil for wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2015: CD006259. https:\/\/doi.org\/10.1002\/14651858.CD006259.pub2.","DOI":"10.1002\/14651858.CD006259.pub2"},{"key":"687_CR27","doi-asserted-by":"publisher","unstructured":"Eldaly MA, Bunce C, ElSheikha OZ, Wormald R. Non\u2010penetrating filtration surgery versus trabeculectomy for open\u2010angle glaucoma. Cochrane Database Syst Rev. 2014: CD007059. https:\/\/doi.org\/10.1002\/14651858.CD007059.pub2.","DOI":"10.1002\/14651858.CD007059.pub2"},{"key":"687_CR28","doi-asserted-by":"publisher","unstructured":"Tseng VL, Coleman AL, Chang MY, Caprioli J. Aqueous shunts for glaucoma. Cochrane Database Syst Rev. 2017: CD004918. https:\/\/doi.org\/10.1002\/14651858.CD004918.pub3.","DOI":"10.1002\/14651858.CD004918.pub3"},{"key":"687_CR29","doi-asserted-by":"publisher","unstructured":"Foo VHX, Htoon HM, Welsbie DS, Perera SA. Aqueous shunts with mitomycin C versus aqueous shunts alone for glaucoma. Cochrane Database Syst Rev. 2019:CD011875. https:\/\/doi.org\/10.1002\/14651858.CD011875.pub2.","DOI":"10.1002\/14651858.CD011875.pub2"},{"key":"687_CR30","doi-asserted-by":"publisher","unstructured":"Wang X, Khan R, Coleman A. Device\u2010modified trabeculectomy for glaucoma. Cochrane Database Syst Rev. 2015:CD010472. https:\/\/doi.org\/10.1002\/14651858.CD010472.pub2.","DOI":"10.1002\/14651858.CD010472.pub2"},{"key":"687_CR31","doi-asserted-by":"publisher","unstructured":"Al\u2010Haddad C, Abdulaal M, Al\u2010Moujahed A, Ervin AM. Fornix\u2010based versus limbal\u2010based conjunctival trabeculectomy flaps for glaucoma. Cochrane Database Syst Rev. 2015:CD009380. https:\/\/doi.org\/10.1002\/14651858.CD009380.pub2.","DOI":"10.1002\/14651858.CD009380.pub2"},{"key":"687_CR32","doi-asserted-by":"publisher","unstructured":"Hu K, Gazzard G, Bunce C, Wormald R. Ab interno trabecular bypass surgery with Trabectome for open angle glaucoma. Cochrane Database Syst Rev. 2016:CD011693. https:\/\/doi.org\/10.1002\/14651858.CD011693.pub2.","DOI":"10.1002\/14651858.CD011693.pub2"},{"key":"687_CR33","doi-asserted-by":"publisher","unstructured":"Otarola F, Hu K, Gazzard G, Bunce C. Ab interno trabecular bypass surgery with Schlemm\u00b4s Canal Microstent (Hydrus) for open angle glaucoma. Cochrane Database Syst Rev. 2017:CD012740. https:\/\/doi.org\/10.1002\/14651858.CD012740.","DOI":"10.1002\/14651858.CD012740"},{"key":"687_CR34","doi-asserted-by":"publisher","unstructured":"T\u00f3th M, Shah A, Hu K, Bunce C, Gazzard G. Endoscopic cyclophotocoagulation (ECP) for open angle glaucoma and primary angle closure. Cochrane Database Syst Rev. 2019: CD012741. https:\/\/doi.org\/10.1002\/14651858.CD012741.pub2.","DOI":"10.1002\/14651858.CD012741.pub2"},{"key":"687_CR35","doi-asserted-by":"publisher","unstructured":"King AJ, Shah A, Nikita E, Hu K, Mulvaney CA, Stead R, et al. Subconjunctival draining minimally\u2010invasive glaucoma devices for medically uncontrolled glaucoma. Cochrane Database Syst Rev. 2018: CD012742. https:\/\/doi.org\/10.1002\/14651858.CD012742.pub2.","DOI":"10.1002\/14651858.CD012742.pub2"},{"key":"687_CR36","doi-asserted-by":"publisher","unstructured":"Le JT, Bicket AK, Wang L, Li T. Ab interno trabecular bypass surgery with iStent for open\u2010angle glaucoma. Cochrane Database Syst Rev. 2019:CD012743. https:\/\/doi.org\/10.1002\/14651858.CD012743.pub2.","DOI":"10.1002\/14651858.CD012743.pub2"},{"key":"687_CR37","doi-asserted-by":"publisher","unstructured":"Sandhu A, Jayaram H, Hu K, Bunce C, Gazzard G. Ab interno supraciliary microstent surgery for open angle glaucoma. Cochrane Database Syst Rev. 2017:CD012802. https:\/\/doi.org\/10.1002\/14651858.CD012802.","DOI":"10.1002\/14651858.CD012802"},{"key":"687_CR38","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ophtha.2015.09.005","volume":"123","author":"T Li","year":"2016","unstructured":"Li T, Lindsley K, Rouse B, Hong H, Shi Q, Friedman DS. et al. Comparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysis. Ophthalmology. 2016;123:129\u201340. https:\/\/doi.org\/10.1016\/j.ophtha.2015.09.005.ISSN 0161-6420.","journal-title":"Ophthalmology"},{"key":"687_CR39","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1755-3768.2009.01819.x","volume":"88","author":"L Schmetterer","year":"2010","unstructured":"Schmetterer L. Are all glaucoma drugs equally effective? Acta Ophthalmol. 2010;88:503.","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"687_CR40","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/bjo.2010.196899","volume":"96","author":"Daniel R Agarwal","year":"2011","unstructured":"Agarwal DR, Ehrlich JR, Shimmyo M, Radcliffe NM. The relationship between corneal hysteresis and the magnitude of intraocular pressure reduction with topical prostaglandin therapy. Br J Ophthalmol. 2012;96:254\u20137.","journal-title":"British Journal of Ophthalmology"},{"key":"687_CR41","doi-asserted-by":"crossref","unstructured":"Sena DF, Lindsley K. Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev. 2017:CD006539.","DOI":"10.1002\/14651858.CD006539.pub4"},{"key":"687_CR42","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","volume":"151","author":"T Krupin","year":"2011","unstructured":"Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S, Low-Pressure Glaucoma Study Group. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study. Am J Ophthalmol. 2011;151:671\u201381.","journal-title":"Am J Ophthalmol"},{"key":"687_CR43","doi-asserted-by":"crossref","unstructured":"European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th ed. Br J Ophthalmol. 2017;101:73\u2013195","DOI":"10.1136\/bjophthalmol-2016-EGSguideline.002"},{"key":"687_CR44","volume-title":"Clinical practice guidelines we can trust","author":"Institute of Medicine.","year":"2011","unstructured":"Institute of Medicine. Clinical practice guidelines we can trust. Washington, DC: The National Academies Press; 2011."},{"issue":"5","key":"687_CR45","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamaophthalmol.2018.0786","volume":"136","author":"Asieh Golozar","year":"2018","unstructured":"Golozar A, Chen Y, Lindsley K, Rouse B, Musch DC, Lum F, et al. Identification and description of reliable evidence for 2016 American Academy of Ophthalmology preferred practice pattern cataract in the adult eye. JAMA Ophthalmol. 2018;136:514\u201323","journal-title":"JAMA Ophthalmology"},{"key":"687_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-017-0561-9","volume":"17","author":"E Mayo-Wilson","year":"2017","unstructured":"Mayo-Wilson E, Ng SM, Chuck RS, Li T. The quality of systematic reviews about interventions for refractive error can be improved: a review of systematic reviews. BMC Ophthalmol 2017;17:164.","journal-title":"BMC Ophthalmol"},{"key":"687_CR47","unstructured":"Saldanha IJ, Lindsley K, Lum F, Dickersin K. Systematic reviews addressing corneal disease: The reliability of the evidence. (In preparation)"},{"issue":"Jun","key":"687_CR48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/IJG.0000000000000301","volume":"25","author":"R Ismail","year":"2016","unstructured":"Ismail R, Azuara-Blanco A, Ramsay CR. Consensus on outcome measures for glaucoma effectiveness trials: results from a Delphi and nominal group technique approaches. J Glaucoma 2016;25(Jun):539\u201346.","journal-title":"J Glaucoma"},{"key":"687_CR49","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bjophthalmol-2013-304323","volume":"98","author":"R Ismail","year":"2014","unstructured":"Ismail R, Azuara-Blanco A, Ramsay CR. Variation of clinical outcomes used in glaucoma randomised controlled trials: a systematic review. Br J Ophthalmol. 2014;98:464\u20138.","journal-title":"Br J Ophthalmol"},{"key":"687_CR50","unstructured":"Core Outcome Measures in Effectiveness Trials. 2011\u20132019. http:\/\/www.comet-initiative.org\/"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0687-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41433-019-0687-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:09:10Z","timestamp":1684602550000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-019-0687-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,3]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1038\/s41433-019-0687-5","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,3]]},"assertion":[{"value":"3 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}